Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Aurora Cannabis Inc

Healthcare US ACB

3.51USD
0.09(2.63%)

Last update at 2026-06-04T20:00:00Z

Day Range

3.433.61
LowHigh

52 Week Range

3.076.67
LowHigh

Fundamentals

  • Previous Close 3.42
  • Market Cap210.49M
  • Volume657530
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-32.73500M
  • Revenue TTM373.12M
  • Revenue Per Share TTM6.64
  • Gross Profit TTM 134.42M
  • Diluted EPS TTM-1.09

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-06-30 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-06-30 2022-03-31
Income before tax 20.38M -59.59900M -295.41926M -1720.12000M -1720.12000M
Minority interest - - 2.06M 0.35M 0.35M
Net income 1.59M -69.32600M -265.32867M -1717.62400M -1717.62400M
Selling general administrative 110.19M 104.94M 68.22M 126.97M 126.97M
Selling and marketing expenses 56.28M 51.94M 51.97M 62.02M 62.02M
Gross profit 187.61M 131.46M -64.35984M 21.23M 21.23M
Reconciled depreciation 22.55M 33.07M 65.23M 93.66M 93.66M
Ebit 28.80M -12.59700M -254.31803M -236.74900M -236.74900M
Ebitda 51.35M 20.47M -210.74481M -143.08900M -143.08900M
Depreciation and amortization 22.55M 33.07M 43.57M 93.66M 93.66M
Non operating income net other - - - - -
Operating income 4.95M -46.45300M -254.31803M -231.44900M -231.44900M
Other operating expenses 338.35M 297.36M 487.61M 440.71M 440.71M
Interest expense 8.42M 14.19M 39.46M 71.81M 71.81M
Tax provision 4.62M -0.55400M -13.64000M -2.14100M -2.14100M
Interest income 11.51M 12.81M 9.88M 4.51M 4.51M
Net interest income 3.08M -1.37300M -51.52500M -67.30600M -67.30600M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 4.62M -0.55400M -20.31595M -2.14100M -2.14100M
Total revenue 343.29M 270.28M 233.29M 221.34M 221.34M
Total operating expenses 182.66M 158.54M 189.96M 240.60M 240.60M
Cost of revenue 155.69M 138.82M 297.65M 200.11M 200.11M
Total other income expense net 15.43M -31.14700M -41.10123M -1433.43900M -1433.43900M
Discontinued operations - - - - -
Net income from continuing ops 15.76M -59.04500M -1750.02200M -1717.97900M -1717.97900M
Net income applicable to common shares - - - -1717.62400M -1717.62400M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-06-30 2023-03-31 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-06-30 2023-03-31 2022-06-30
Total assets 847.77M 838.67M 926.32M 926.32M 1084.36M
Intangible assets 44.90M 40.85M 61.40M 61.40M 70.70M
Earning assets - - - - -
Other current assets 10.82M 9.40M 8.92M 8.92M 6.54M
Total liab 242.67M 236.80M 409.19M 409.19M 422.00M
Total stockholder equity 563.91M 559.77M 486.08M 486.08M 661.84M
Deferred long term liab - - - - -
Other current liab 44.84M 21.02M 71.07M 48.97M 94.52M
Common stock 6950.98M 6971.42M 6841.23M 6841.23M 6754.63M
Capital stock 6991.15M 6971.42M - - 6754.63M
Retained earnings -6331.15278M -6367.93600M -6296.83300M -6296.83300M -6038.27500M
Other liab - - - - 40.29M
Good will 43.62M 43.18M 18.71M 18.71M 0.00000M
Other assets - - - - 33.87M
Cash 184.26M 113.44M 300.84M 300.84M 437.81M
Cash and equivalents - - - - -
Total current liabilities 110.23M 124.62M 242.31M 242.31M 145.23M
Current deferred revenue 1.07M 1.69M 1.74M 1.74M 3.85M
Net debt -80.28100M -8.64800M -73.32000M -73.32000M -168.31600M
Short term debt 26.74M 57.22M 147.56M 147.56M 33.00M
Short long term debt 21.51M 52.36M - - 26.85M
Short long term debt total 103.98M 104.79M 227.52M 227.52M 269.49M
Other stockholder equity - - -0.00000M -0.00000M -54.50800M
Property plant equipment - - - - 230.30M
Total current assets 475.58M 426.61M 479.93M 479.93M 745.12M
Long term investments - - - - 1.21M
Net tangible assets - - - - 587.99M
Short term investments 0.55M 4.04M - - 1.33M
Net receivables 42.23M 45.41M 41.34M 41.34M 47.05M
Long term debt 40.19M 4.90M - - 199.65M
Inventory 237.72M 186.38M 128.82M 128.82M 139.93M
Accounts payable 27.46M 20.32M 21.94M 21.94M 13.86M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -55.91483M -43.70700M -58.32500M -58.32500M -54.50800M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 7.68M 12.03M 14.06M 14.06M 33.87M
Deferred long term asset charges - - - - -
Non current assets total 372.19M 412.07M 446.39M 446.39M 339.24M
Capital lease obligations 42.88M 47.53M - - 42.99M
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-06-30 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-06-30 2022-03-31
Investments -14.32700M -5.48700M -54.67400M -36.60000M -36.60000M
Change to liabilities - - - 3.31M 3.31M
Total cashflows from investing activities -14.32700M - - -36.60000M -36.60000M
Net borrowings -0.80500M - - -170.83100M -170.83100M
Total cash from financing activities -0.11600M -47.92300M -56.47800M 147.78M 147.78M
Change to operating activities - - - 6.47M 6.47M
Net income 15.76M -59.04500M -265.32867M -1717.97900M -1717.97900M
Change in cash 1.83M -121.50300M -140.00900M 16.35M 16.35M
Begin period cash flow 136.09M 234.94M 440.85M 421.46M 421.46M
End period cash flow 137.92M 113.44M 300.84M 437.81M 437.81M
Total cash from operating activities 16.00M -68.50800M -115.82100M -109.83800M -109.83800M
Issuance of capital stock 0.00000M 37.93M 417.75M 350.19M 350.19M
Depreciation 22.55M 33.07M 43.57M 93.66M 93.66M
Other cashflows from investing activities -0.95600M - - -0.18500M -0.18500M
Dividends paid - - - - -
Change to inventory -15.04900M 3.62M 49.03M 21.07M 21.07M
Change to account receivables 5.24M -4.33300M 5.53M 18.76M 18.76M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.13100M -5.48700M -95.20798M -31.57800M -31.57800M
Change to netincome - - - 1464.18M 1464.18M
Capital expenditures 18.86M 16.96M 12.13M 32.21M 32.21M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 10.21M -15.62700M -25.11600M 49.95M 49.95M
Stock based compensation 11.52M 12.72M 16.89M 13.76M 13.76M
Other non cash items -40.84900M -70.84100M 190.11M 1452.97M 1452.97M
Free cash flow -2.85400M -85.46400M -127.95300M -142.05100M -142.05100M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ACB
Aurora Cannabis Inc		 0.09 2.63% 3.51 - 19.16 0.56 0.57 0.79 12.13
ZTS
Zoetis Inc		 1.93 2.49% 79.52 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 1.31 4.22% 32.32 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 14.53 9.74% 163.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.34 0.83% 40.58 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

90B Street SW, Edmonton, AB, Canada, T6X 1V8

Key Executives

Name Title Year Born
Mr. Miguel Martin CEO & Director 1972
Mr. Glen Ibbott Chief Financial Officer NA
Mr. Alex Miller Exec. VP of Operations & Supply Chain NA
Ms. Lori Schick Exec. VP of HR NA
Mr. Andre Jerome Exec. VP of Global Bus. Devel. NA
Ananth Krishnan VP of Capital Markets & Investor Relations NA
Mr. Nathalie Clark Exec. VP, Gen. Counsel & Corp. Sec. NA
Michelle Lefler VP of Communications & PR NA
Mr. Carey Squires Exec. VP of Corp. Devel. & Strategy NA
Mr. John Barnet Chief Cultivator NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.